Torrent Pharmaceuticals Ltd
₹4,181+0.62%Apr 13, 3:45 PM IST
TORNTPHARM•Health Technology•Pharmaceuticals: Major
Current Price
₹4,181+0.62%
Apr 13, 3:45 PM ISTMarket Cap₹1,40,696.27 Cr
Market Cap₹1,40,696.27 Cr
Business Overview
Torrent Pharmaceuticals Limited operates through 2 main business divisions including Branded Generics (BGx), Generics (Gx).
Business Hierarchy Structure for Torrent Pharmaceuticals Limited
- Torrent Pharmaceuticals Limited
- Branded Generics (BGx)
- Therapeutic Areas
- Cardiovascular (CV)
- Central Nervous System (CNS)
- Gastro-Intestinal (GI)
- Vitamin Mineral Nutrients (VMN)
- Dermatology
- Diabetology
- Pain Management
- Oncology
- Gynaecology
- Cosmo-Dermatology
- Anti-Diabetes
- Consumer Health (CHC) Segment
- CHC Brands
- Shelcal 500
- Unienzyme Tablet
- Ahaglow
- Tedibar
- CHC Brands
- India Products
- Top Brands
- Shelcal 500
- Nikoran 5
- Nexpro RD 40
- Chymoral Forte
- Unienzyme XT
- New Launches
- Nebicard T
- Stalix D
- Lasmiray 50
- Rozucor F 10
- Sitaxa M 50 + 500
- Vorxar
- Linaxa
- Top Brands
- Brazil Products
- Torval CR
- Indapen SR
- Venlift OD
- Lamitor CD
- Azukon MR
- Rosucor
- Olmecor
- Olmecor Triplo
- Ivahart
- Tiag
- Veepi
- Neblock
- Therapeutic Areas
- Generics (Gx)
- Focus Markets
- US Market
- Europe Market
- Emerging Markets
- Focus Markets
- Branded Generics (BGx)